Fifty 1 Labs, Inc. (FITY)
OTCMKTS · Delayed Price · Currency is USD
0.0006
0.00 (0.00%)
At close: Jul 27, 2026
Fifty 1 Labs Revenue
Fifty 1 Labs had revenue of $998.05K in the quarter ending March 31, 2011, a decrease of -20.87%. This brings the company's revenue in the last twelve months to $4.08M, down -29.40% year-over-year. In the fiscal year ending June 30, 2010, Fifty 1 Labs had annual revenue of $5.11M, down -5.64%.
Revenue (ttm)
4.08M
Revenue Growth
-29.40%
P/S Ratio
0.17
Revenue / Employee
163.06K
Employees
25
Market Cap
710.92K
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2010 | 5.11M | -305.13K | -5.64% |
| Jun 30, 2009 | 5.41M | 905.69K | 20.10% |
| Jun 30, 2008 | 4.51M | -2.44M | -35.11% |
| Jun 30, 2007 | 6.94M | -4.74M | -40.57% |
| Jun 30, 2006 | 11.68M | 9.59M | 458.26% |
| Jun 30, 2005 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Tian'an Pharmaceutical | 10.65M |
| Target Group | 3.36M |
| Cannabis Global | 1.06M |
| LiveWire Ergogenics | 571.68K |
| Demand Brands | 165.00K |
| ViaDerma | 44.69K |
| Pharmagreen Biotech | 3.00K |
Fifty 1 Labs News
- 17 days ago - Fifty 1 Labs Announces Strategic Evolution into Peptide Biotechnology and Telehealth - Accesswire
- 3 months ago - Fifty 1 Labs, Inc. Accelerates Peptide Biotechnology Push into Musculoskeletal Health - Accesswire
- 3 months ago - Fifty 1 Labs, Inc. Eliminates 612 Million Shares from the Market - Accesswire
- 7 months ago - Fifty1 Labs, Inc. Clarifies Status Regarding Previously Announced Collaboration with LUNR Aerospace - GlobeNewsWire
- 10 months ago - Fifty 1 Labs Inc. Appoints Dr. Joel Gagnier as Chief Science Officer - GlobeNewsWire
- 10 months ago - Fifty 1 Labs Inc. Signs Letter of Intent to Acquire BioSpark AI Technologies Inc. - GlobeNewsWire
- 10 months ago - Fifty 1 Labs, Inc. Engages PCAOB Auditing Firm to Prepare for Uplist to OTCQB - GlobeNewsWire
- 11 months ago - Fifty1 Labs, Inc. Leadership Publishes Landmark Framework to Unlock Global Oncology Data Through AI-Driven Real-World Evidence - GlobeNewsWire